The FDA Says This Weight Loss Treatment Just Got Riskier
The FDA recently issued an alert to healthcare providers, warning them that the fluid-filled weight loss devices may "[over-inflate] with air or more fluid (spontaneous hyperinflation) in patients' stomachs, resulting in the need for premature device removal." In the letter, the FDA also noted that the "second type of adverse event is the development of acute pancreatitis," which also requires the weight loss balloons to be removed.
While the "root cause and incidence of these complications is not known," the agency adds that there are no issues with Obalon, the first FDA-approved swallowable balloon that uses air instead of fluid to help patients lose weight.
Looking for another non-invasive way to lose pounds? Check out our video on CoolSculpting below: